Your browser doesn't support javascript.
loading
The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P1) and hypertension (S1P3) in rat.
Fryer, Ryan M; Muthukumarana, Akalushi; Harrison, Paul C; Nodop Mazurek, Suzanne; Chen, Rong Rhonda; Harrington, Kyle E; Dinallo, Roger M; Horan, Joshua C; Patnaude, Lori; Modis, Louise K; Reinhart, Glenn A.
Affiliation
  • Fryer RM; Department of Cardiometabolic Disease Research, Boehringer-Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, United States of America. ryan.fryer@boehringer-ingelheim.com
PLoS One ; 7(12): e52985, 2012.
Article in En | MEDLINE | ID: mdl-23285242

Full text: 1 Database: MEDLINE Main subject: Propylene Glycols / Sphingosine / Azetidines / Benzyl Compounds / Bradycardia / Receptors, Lysosphingolipid / Hypertension Limits: Animals / Humans / Male Language: En Year: 2012 Type: Article

Full text: 1 Database: MEDLINE Main subject: Propylene Glycols / Sphingosine / Azetidines / Benzyl Compounds / Bradycardia / Receptors, Lysosphingolipid / Hypertension Limits: Animals / Humans / Male Language: En Year: 2012 Type: Article